SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
The Tax-Dodging Marriage of Viagra and Botox
Throughout the fall, Pfizer, the maker of Viagra, has been courting Allergan, the manufacturer of Botox. Pfizer was not attracted by Allergan's wrinkle-free face or full lips, but by its Irish "citizenship."
Dec 09, 2015
Throughout the fall, Pfizer, the maker of Viagra, has been courting Allergan, the manufacturer of Botox. Pfizer was not attracted by Allergan's wrinkle-free face or full lips, but by its Irish "citizenship."
In its proposal to Allergan, the Viagra-maker whispered, "If we get together, we can really stiff the tax man." In order to fulfill this goal, Pfizer would renounce its U.S. incorporation and take on Allergan's Irish registration. Add into the mix the fact that most of Allergan's employees continue to work in the U.S. (where two-thirds of the company's sales take place) and Pfizer's executives would continue to operate out of New York, and the union becomes very questionable. But when tax time comes, both would proudly declare with a straight face, "We're Irish," making much of their combined income off-limits to U.S. tax collectors.
Pfizer is far from the first major U.S. firm to undertake this tax dodge in an attempt to avoid its responsibility to pay taxes. Since the 1980s, more than 50 U.S. multinational firms have executed the maneuver, known as a corporate inversion.
"By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years."
President Obama called Pfizer's move "unpatriotic," and he has urged legislators to close the loopholes in the tax code that make such a merger possible.
While corporate executives were celebrating the proposed merger, others at Pfizer were continuing normal operations, which draw heavily on taxpayer-funded services and subsidies designed to support American businesses.
For example, in the days following the announcement of the merger, Pfizer joined other pharmaceutical companies in calling on Congress to enact a new law making it easier for drug giants to use federal courts to pursue trade secrets claims against their competitors.
We, as taxpayers, help American businesses pay for everything from their research and development to highways to deliver their products. According to Pfizer's filings with the Securities and Exchange Commission (SEC), in 2014, taxpayers provided Pfizer and its shareholders with $110 million* through the Research and Experimentation and Domestic Manufacturing tax credits alone.
By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years. It doesn't want to help pay for the public universities that have educated many of its scientists, nor is it willing to help pay for the roads, airports, and postal services the company relies on to get its products to consumers.
What's the prescription for curing Pfizer's allergy to paying taxes?
Congress and the Treasury Department could start by limiting access of inverted companies like Pfizer to taxpayer-funded services and public subsidies. If companies choose to renounce their U.S. incorporation, why should they continue to receive subsidies to support their research costs or continue to be able to defend their patents in U.S. courts or to enjoy the lucrative profits that come from tax dollars that pay for drugs for Medicare beneficiaries?
Lawmakers should also require inverted companies to pay the taxes they already owe on past profits they've already stashed offshore. In Pfizer's case, the U.S. would receive a check for tens of billions of dollars once the Allergan merger is consummated.
Legal tax dodging is weakening our economy and leaving us all worse off. Our nation only works for all of us when everyone plays by the same rules and every actor - citizen and corporation - pays their fair share. After all, these CEOs and their employees still live and work in America.
Congress knows the prescription for change: change the rules to make inversion marriages unattractive and unprofitable. If your congressional representative refuses to dispense this policy pill to Pfizer and other companies like it, then consider a political inversion and elect someone new.
*Correction: An earlier version of this piece included a miscalculated total for this figure which has now been corrected.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Scott Klinger
Scott Klinger is researcher with the Program on Inequality at the Institute for Policy Studies (www.inequality.org).
Throughout the fall, Pfizer, the maker of Viagra, has been courting Allergan, the manufacturer of Botox. Pfizer was not attracted by Allergan's wrinkle-free face or full lips, but by its Irish "citizenship."
In its proposal to Allergan, the Viagra-maker whispered, "If we get together, we can really stiff the tax man." In order to fulfill this goal, Pfizer would renounce its U.S. incorporation and take on Allergan's Irish registration. Add into the mix the fact that most of Allergan's employees continue to work in the U.S. (where two-thirds of the company's sales take place) and Pfizer's executives would continue to operate out of New York, and the union becomes very questionable. But when tax time comes, both would proudly declare with a straight face, "We're Irish," making much of their combined income off-limits to U.S. tax collectors.
Pfizer is far from the first major U.S. firm to undertake this tax dodge in an attempt to avoid its responsibility to pay taxes. Since the 1980s, more than 50 U.S. multinational firms have executed the maneuver, known as a corporate inversion.
"By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years."
President Obama called Pfizer's move "unpatriotic," and he has urged legislators to close the loopholes in the tax code that make such a merger possible.
While corporate executives were celebrating the proposed merger, others at Pfizer were continuing normal operations, which draw heavily on taxpayer-funded services and subsidies designed to support American businesses.
For example, in the days following the announcement of the merger, Pfizer joined other pharmaceutical companies in calling on Congress to enact a new law making it easier for drug giants to use federal courts to pursue trade secrets claims against their competitors.
We, as taxpayers, help American businesses pay for everything from their research and development to highways to deliver their products. According to Pfizer's filings with the Securities and Exchange Commission (SEC), in 2014, taxpayers provided Pfizer and its shareholders with $110 million* through the Research and Experimentation and Domestic Manufacturing tax credits alone.
By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years. It doesn't want to help pay for the public universities that have educated many of its scientists, nor is it willing to help pay for the roads, airports, and postal services the company relies on to get its products to consumers.
What's the prescription for curing Pfizer's allergy to paying taxes?
Congress and the Treasury Department could start by limiting access of inverted companies like Pfizer to taxpayer-funded services and public subsidies. If companies choose to renounce their U.S. incorporation, why should they continue to receive subsidies to support their research costs or continue to be able to defend their patents in U.S. courts or to enjoy the lucrative profits that come from tax dollars that pay for drugs for Medicare beneficiaries?
Lawmakers should also require inverted companies to pay the taxes they already owe on past profits they've already stashed offshore. In Pfizer's case, the U.S. would receive a check for tens of billions of dollars once the Allergan merger is consummated.
Legal tax dodging is weakening our economy and leaving us all worse off. Our nation only works for all of us when everyone plays by the same rules and every actor - citizen and corporation - pays their fair share. After all, these CEOs and their employees still live and work in America.
Congress knows the prescription for change: change the rules to make inversion marriages unattractive and unprofitable. If your congressional representative refuses to dispense this policy pill to Pfizer and other companies like it, then consider a political inversion and elect someone new.
*Correction: An earlier version of this piece included a miscalculated total for this figure which has now been corrected.
Scott Klinger
Scott Klinger is researcher with the Program on Inequality at the Institute for Policy Studies (www.inequality.org).
Throughout the fall, Pfizer, the maker of Viagra, has been courting Allergan, the manufacturer of Botox. Pfizer was not attracted by Allergan's wrinkle-free face or full lips, but by its Irish "citizenship."
In its proposal to Allergan, the Viagra-maker whispered, "If we get together, we can really stiff the tax man." In order to fulfill this goal, Pfizer would renounce its U.S. incorporation and take on Allergan's Irish registration. Add into the mix the fact that most of Allergan's employees continue to work in the U.S. (where two-thirds of the company's sales take place) and Pfizer's executives would continue to operate out of New York, and the union becomes very questionable. But when tax time comes, both would proudly declare with a straight face, "We're Irish," making much of their combined income off-limits to U.S. tax collectors.
Pfizer is far from the first major U.S. firm to undertake this tax dodge in an attempt to avoid its responsibility to pay taxes. Since the 1980s, more than 50 U.S. multinational firms have executed the maneuver, known as a corporate inversion.
"By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years."
President Obama called Pfizer's move "unpatriotic," and he has urged legislators to close the loopholes in the tax code that make such a merger possible.
While corporate executives were celebrating the proposed merger, others at Pfizer were continuing normal operations, which draw heavily on taxpayer-funded services and subsidies designed to support American businesses.
For example, in the days following the announcement of the merger, Pfizer joined other pharmaceutical companies in calling on Congress to enact a new law making it easier for drug giants to use federal courts to pursue trade secrets claims against their competitors.
We, as taxpayers, help American businesses pay for everything from their research and development to highways to deliver their products. According to Pfizer's filings with the Securities and Exchange Commission (SEC), in 2014, taxpayers provided Pfizer and its shareholders with $110 million* through the Research and Experimentation and Domestic Manufacturing tax credits alone.
By attempting to invert, Pfizer is declaring that it wants no part in paying for all of the public services that have allowed the company to grow and thrive over the last 166 years. It doesn't want to help pay for the public universities that have educated many of its scientists, nor is it willing to help pay for the roads, airports, and postal services the company relies on to get its products to consumers.
What's the prescription for curing Pfizer's allergy to paying taxes?
Congress and the Treasury Department could start by limiting access of inverted companies like Pfizer to taxpayer-funded services and public subsidies. If companies choose to renounce their U.S. incorporation, why should they continue to receive subsidies to support their research costs or continue to be able to defend their patents in U.S. courts or to enjoy the lucrative profits that come from tax dollars that pay for drugs for Medicare beneficiaries?
Lawmakers should also require inverted companies to pay the taxes they already owe on past profits they've already stashed offshore. In Pfizer's case, the U.S. would receive a check for tens of billions of dollars once the Allergan merger is consummated.
Legal tax dodging is weakening our economy and leaving us all worse off. Our nation only works for all of us when everyone plays by the same rules and every actor - citizen and corporation - pays their fair share. After all, these CEOs and their employees still live and work in America.
Congress knows the prescription for change: change the rules to make inversion marriages unattractive and unprofitable. If your congressional representative refuses to dispense this policy pill to Pfizer and other companies like it, then consider a political inversion and elect someone new.
*Correction: An earlier version of this piece included a miscalculated total for this figure which has now been corrected.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.